Purpose. The purpose of this study was to evaluate the usefulness of a new diagnostic multiplexed bead-based bioassay (Quantamatrix Multiplexed Assay Platform; QMAP) system with shape-encoded silica microparticles for the rapid and accurate detection and identification of 23 mycobacterial species/groups, including Mycobacterium tuberculosis complex (MTBC).
INTRODUCTION
Tuberculosis (TB) is one of the most prevalent infectious diseases and remains a leading cause of morbidity and mortality worldwide [1] . Mycobacteria are responsible for various types of human infections, especially TB, which has profound individual and public health implications. The World Health Organization estimates that 9.6 million new TB cases are reported annually and are the cause of death in 1.5 million patients [2] . Non-tuberculous mycobacteria (NTM) are frequently isolated from environmental sources, and several species are associated with human disease including pulmonary, skin/soft tissue, lymphatic and disseminated infections [3] . The isolation of clinical specimens of NTM is increasing in many countries, with geographical variations in the prevalent species, whereas the incidence of TB is decreasing [4] , highlighting the importance of implementation strategies for early infection control based on the rapid differentiation between NTM and Mycobacterium tuberculosis complex (MTBC) [5] .
One of the most effective means of protection against mycobacterial infections is early diagnosis and treatment of the disease. Preliminary suspicion of mycobacterial infections is based on clinical findings, but definite diagnosis depends on laboratory methods [6] . MTBC poses diagnostic and therapeutic problems due to the low sensitivity of available diagnostic tools for its identification and discrimination from NTM [7] . The standard diagnosis for mycobacterial infections relies on clinical presentation, histopathology, radiology, tuberculin skin testing/and or interferon gamma release assays for the active TB, acid-fast bacilli (AFB) smears and the isolation of Mycobacterium species from culture [8] . AFB smears and cultures in these diagnostic methods have well-known limitations of low sensitivity and significant labour and time requirements [8, 9] . The rapid detection and accurate identification of Mycobacterium species during the early stages of infection are crucial because the strategies used for the clinical management of patients with MTBC and NTM are different [7, 9] .
Modern molecular techniques for MTBC and NTM diagnosis, including real-time PCR [10] , hybridization [11] , chemiluminescent DNA probes [12] , high-performance liquid chromatography [13] , matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry [14] , PCRrestriction fragment length polymorphism analysis (PRA) of the hsp65 [15] , groES [16] and rpoB [17] genes, and sequence analysis of 16S rRNA genes [9] , allow for faster and more accurate diagnoses than conventional culture-based biochemical methods. A new diagnostic system using a multiplexed bead-based bioassay (Quantamatrix Multiplexed Assay Platform; QMAP) with shape-encoded silica microparticles [18] , QMAP Myco-ID (QuantaMatrix), was developed for the rapid and accurate detection and identification of MTBC and NTM. The 24 multi-probes of the QMAP system targeting Mycobacterium species comprise Mycobacterium genus-specific probes for MTBC, M. avium, M. intracellulare, M. scrofulaceum, M. abscessus complex, M. chelonae, M. fortuitum complex, M. ulcerans/M. marinum, M. kansasii, M. genavense/M. simiae, M. terrae, M. nonchromogenicum, M. celatum, M. gordonae, M. szulgai, M. mucogenicum, M. aubagnense, M. malmoense, M. smegmatis, M. phlei, M. xenopi, M. flavescens and M. peregrinum/M. septicum from clinical samples. The shapeencoded silica microparticles (microdiscs) allow for a coding capacity exceeding 1000 plex and high-throughput analysis; 1000 multiplex is possible in a one-microwell disc type-coded microparticle with graphical barcoded carboxyl-functionalized magnetic discs.
The purpose of the present study was to evaluate the usefulness of the QMAP system for the rapid detection of MTBC, differentiation of MTBC from NTM and identification of major NTM species of liquid or solid samples cultured from the respiratory specimens.
METHODS

Bacterial strains
A total of 108 bacterial strains, including 43 Mycobacterium reference strains, three clinical isolate strains and 62 nonmycobacterial reference strains belonging to 25 different genera (Nocardia, 17 strains; Aspergillus, 7; Candida, 6; Trichophyton, 3; Microsporum, 2; Penicillium, 2; Absidia, 1; Aureobasidium, 1; Bipolaris, 1; Cryptococcus, 1; Curvularia, 1; Fusarium, 1; Kodamea, 1; Malassezia, 1; Saccharomyces, 1; Staphylococcus, 2; Streptococcus, 2; Enterococcus, 1; Shigella 3; Escherichia, 2; Salmonella, 2; Citrobacter, 1; Enterobacter, 1; Klebsiella, 1; and Pseudomonas, 1) were used in this study to determine QMAP system specificity.
Clinical isolates
Clinical isolates were obtained from St Vincent's Hospital (Suwon, Republic of Korea). Inclusion criteria for enrolled specimens included sputum specimens from patients suspected to have TB or NTM diseases based on abnormal chest X-ray or clinical findings. A total of 295 DNA samples extracted from patients suspected of MTBC or NTM pulmonary disease were examined. This study was approved by the Institutional Ethics Committee at St Vincent's Hospital and all subjects provided written informed consent.
AFB smear, culture and conventional Mycobacterium identification method In order to detect AFB, auramine-rhodamine fluorescent staining was performed with sputum specimens, and the results were confirmed using the Ziehl-Neelsen method [19] . Microscopic results were reported semi-quantitatively. A presence of AFB in a specimen was defined as follows: trace, 1 to 2 AFB per Â300 field; 1+, 1 to 9 AFB per Â100 field; 2+, 1 to 9 AFB per Â10 field; 3+, 1 to 9 AFB per Â1 field; and 4+, more than 9 AFB per Â1 field. Sputum specimens were decontaminated using the N-acetyl-L-cysteine (NALC) 2 % NaOH method. NALC-NaOH pretreated sputum specimens were inoculated onto solid agar (Ogawa medium; Asan Pharmaceutical) and liquid medium (MGIT tube; BD Diagnostic Systems). Cultures on Ogawa media were incubated at 37 C under 5 % CO 2 for 8 weeks. Cultures in MGIT tube media were incubated using the BAC-TEC MGIT 960 system (BD Diagnostic Systems) and continuously monitored for 6 weeks. A 1 ml aliquot from each MGIT culture was tested and those with positive signals were subjected to AFB staining to confirm the presence of AFB and exclude contamination. All positive culture isolates were sent to the Korean Institute of Tuberculosis (KIT, Osong, Republic of Korea), which served as a reference laboratory using conventional microbiological and biochemical tests for the identification and classification of mycobacteria and antimicrobial susceptibility testing.
DNA preparation
To prepare DNA samples for the QMAP testing, a 1 ml aliquot of culture broth from the BACTEC aliquot was centrifuged for 10 min at 13 000 g. Each cell sample was extracted with DNA extraction solution (Optipharm), and the suspended bacterial solution was boiled for 10 min. The isolated genomic DNA was stored at À20 C and was used after it was completely dissolved for PCR amplification.
Real-time PCR
In order to differentiate between MTB and NTM, and compare results from the QMAP system, DNA samples were extracted from clinical specimens and amplified using the Real MTB-ID PCR kit (YD Diagnostics) following the manufacturer's protocol. A positive result was indicated when the cycle threshold (C t ) value was less than 35 after observing signal formation of a wavelength from each channel (FAM, HEX and Cy5).
PCR-reverse blot hybridization assay (REBA)
For the rapid identification of Mycobacterium species from clinical culture-positive samples, the REBA Myco-ID assay (YD Diagnostics) was performed according to the manufacturer's instructions (Fig. 1) . In brief, PCR was performed using 20 µl of the reaction mixture (Genet Bio) containing 2Â master mix, 1Âbiotinylated primer mixture, 5 µl of sample DNA, and ddH 2 O to give a final volume of 20 µl. The 40 PCR cycles consisted of an initial denaturation at 95 C for 30 s, followed by annealing and extension at 65 C for 30 s. After the final cycle, samples were maintained at 72 C for 10 min to complete the synthesis of all strands. The amplified target was visualized as a single band corresponding to a length of 250 bp using the Chemi Doc system (Vilber Lourmat). The amplified PCR products were then subjected to REBA. Hybridization and washing were performed according to the manufacturer's instructions. In brief, biotinylated PCR products were denatured at 25 C for 5 min in denaturation solution, diluted in 970 µl of hybridization solution, and added to the REBA membrane strip in the provided blotting tray. Denatured single-stranded PCR products were hybridized with the probes on the strip at 55 C for 30 min. The strips were then washed twice with gentle shaking in 1.0 ml of washing solution for 10 min at 55 C, incubated at 25 C with 1 : 2000 diluted streptavidin-alkaline phosphatase conjugate (Roche Diagnostics) in conjugate diluent solution (CDS; 50 mM Tris, 150 mM NaCl, pH 7.5) for 30 min, and washed twice with 1.0 ml of CDS at room temperature for 1 min. The colorimetric hybridization signals were visualized by adding 1 : 50 diluted alkaline phosphatase-mediated staining solution and NBT/BCIP (Roche Diagnostics), which was subsequently incubated until the colour was detected. Finally, the band pattern was read and interpreted.
PCR-restriction fragment length polymorphism analysis (PRA) In order to identify major NTM species and compare identification results from the PCR-REBA, the PRA Myco-ID kit (YD Diagnostics) was used according to the manufacturer's instructions (Fig. 1) . Briefly, the primer sets used to amplify the target rpoB gene were 5¢-TCAAGGAGAAGCGCTAC-GA-3¢ (RPO5¢) and 5¢-GGATGTTGATCAGGGTCTGC-3¢ (RPO3¢), which resulted in a 360 bp PCR product [17] . PCR was performed using a 50 µl reaction mixture (Genet Bio) containing 2Â master mix, 10 pmol of each primer, 10 µl of DNA supernatant containing approximately 10 ng of genomic DNA, and ddH 2 O added to give a final volume of 50 µl. The 35 PCR cycles comprised an initial denaturation at 94 C for 1 min, followed by annealing at 58 C for 1 min and extension at 72 C for 1 min. After the final cycle, samples were maintained at 72 C for 10 min to complete the synthesis of all strands. The amplified product was digested using restriction enzymes. A 10-16 µl aliquot of the PCR products (approximately 1.0-1.5 mg of genomic DNA) was restricted in two, 20 µl digestion reactions that contained 5.0 U of restriction enzyme (MspI and HaeIII) and enzyme reaction buffer. After incubation at 37 C for 2 h, 4.0 ml of gel loading buffer (0.25 % bromophenol blue and 40 % sucrose in ddH 2 O) was added and samples were loaded onto a 4 % MetaPhor agarose gel (FMC BioProducts). Then, enzyme-digested fragments were separated by electrophoresis and visualized under UV light after ethidium bromide staining. The restriction fragment size for each NTM species was determined using standard PRA size markers and the algorithm was constructed using this information.
Quantamatrix Multiplexed Assay Platform (QMAP) system For the rapid identification of Mycobacterium species from positive clinical culture samples, MTB H37Rv, 45 NTM strains and 62 non-Mycobacterium strains were used to determine the specificity of the QMAP system. QMAP testing was performed according to manufacturer's instructions. 5¢-Amine modifications of 24 Mycobacterium genus-and species-specific oligonucleotide probes were coupled to the carboxylated microdiscs, and each of the target Mycobacterium species genes was complementary to a single probe. In brief, the steps for PCR were performed in the same way as described above for PCR-REBA. Biotinylated PCR products were denatured at 25 C for 5 min in denaturation solution, diluted in 45 µl of hybridization solution and added to coupled-microdiscs in the provided glass MatriPlate (Brooks). Denatured single-stranded PCR products were hybridized with the coupled probes on the microdiscs at 40 C for 30 min. The microdiscs were then washed three times with gentle shaking in 120 µl of washing solution for 1 min at 25 C, incubated at 25 C with 1 : 2000 diluted streptavidin R-phycoerythrin conjugate (Prozyme) for 10 min, and washed three times with 120 µl of washing solution at room temperature for 1 min. Finally, bright-field and fluorescence microscopy images were obtained for data analysis. The fluorescence intensity of all microdiscs in the image was automatically measured using provided software. The cutoff value for distinguishing between positive and negative results was a fluorescence intensity signal of 500 (Fig. 2) .
rpoB gene sequence analysis To confirm the identity of samples with discrepant results between the conventional method and the QMAP system for NTM identification, the rpoB gene region was sequenced. The primer sets used to amplify the target rpoB gene were 372 F 5¢-CCTGTTCTTCAAGGAGAAGCGC TACGACCTGG-3¢ and 372 R 5¢-GGACGGATGTTGA TCAGGGTCTGCGG-3¢, which resulted in a 372 bp PCR product. Amplified DNA (rpoB region) was sequenced using the ABI Prism BigDye Terminator kit and an ABI 3730 automated DNA sequencer (Cosmo Genetech). The sequences obtained were compared with sequences in the National Center for Biotechnology Information (NCBI) GenBank database for species assignment.
Statistical analysis
All statistical analyses were performed using SPSS statistics software version 22.0 (IBM). The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the QMAP system were calculated, and 95 % confidence intervals (CIs) were estimated. A P<0.05 was considered statistically significant.
RESULTS
Specificity of the QMAP system with bacterial reference strains The Mycobacterium genus-specific probe of the QMAP system was positive for all 46 Mycobacterium species and three Table 2) .
Validation of the QMAP test
We evaluated the usefulness of the QMAP system for the rapid detection of MTBC, differentiation of MTBC from NTM, and the identification of major NTM species from a total of 295 liquid culture-positives from respiratory specimens (Table 3) . Of 295 isolates, 212 and 81 isolates were equally identified as MTB and NTM by the conventional method and the QMAP system ( (Table 4) . 
DISCUSSION
Until recently, NTM were not thought to spread by air inhalation from person to person [20] , but aerosol generation during physiotherapy and lung function testing is now felt to be a possible route of cross-infection of M. abscessus in cystic fibrosis patients [21] . Since reporting NTM pulmonary disease to public health departments is not obligatory, the exact number of those infected with NTM remains unknown. An increase in the frequency of pulmonary and extrapulmonary NTM disease has been indicated in a number of worldwide surveys and population-based studies over the last few decades [22] . Of all Mycobacterium species, the proportion of NTM isolates from sputum specimens obtained at a tertiary-care medical centre in the Republic of Korea increased from 43 % in 2001 to 70 % in 2011, and the NTM recovery rate from AFB smear-positive sputum specimens increased from 9 % in 2001 to 64 % in 2011 [23] . The rapid identification and discrimination of NTM from MTBC are useful for the management of mycobacterial disease because many NTM strains are resistant to the antibiotics used for the treatment of TB. However, the differentiation of mycobacteria to the species level by the evaluation of phenotypic and biochemical testing is timeconsuming and cumbersome. Phenotypic and biochemical test results may vary depending on growth conditions, sometimes leading to inaccurate results. Although rapid distinction of MTBC from NTM is possible with PCR-based methods such as PCR and real-time PCR, these assays are limited in their ability to distinguish between NTM species.
The overall sensitivity and specificity of the QMAP system compared to the conventional method for the identification of all Mycobacterium species were equally 100 %. The overall sensitivity, specificity, PPV and NPV of the QMAP system for MTB and NTM identification were 100 % (212/212, 95 % CI 0.9874-1.0000, P<0.0001) versus 97. respectively. These measures are similar to previously reported sensitivity of 99.7 % and specificity of 99.3 % using a hybridization-based assay [24] and the sensitivity of 73.8-100 %and specificity of 92.3-100 % using a real time PCRbased assay [25] . The findings are higher than the reported sensitivity of 77-88 % andspecificity of 97.9 % using a MALDI-TOF MS-based assay [14] . The major cause of the discrepant identification results between conventional method and the QMAP system was mixed infections, which included four cases in this study. Because conventional culture methods are based on isolation followed by colony identification, they tend to isolate a single species of Mycobacterium with a more rapid growth rate or a dominant cell number in a sample and tend to underestimate the number of isolates among specimens containing more than one Mycobacterium species [26] . The PCR-RFLP method (PRA Myco-ID) discriminates the Mycobacterium species by the specific restriction endonuclease and allows inexpensive detection of species within the sequences of PCR products. However, RFLP typing of an isolate from multiple Mycobacterium species infections will result in a mixture of RFLP patterns. If one of the bacterial populations predominates, the other will be reflected as a background pattern of usually multiple low-intensity bands in the mixed RFLP pattern [27] . Two isolates suspected with NTM on culture media were not identified in the QMAP system and were identified as R. erythropolis and Rhodococcus jostii by rpoB gene sequence analysis or PRA Myco-ID. The reason for these isolates not being detected was due to the selective detection of Mycobacterium species using specific probes in the QMAP system. In the present study, there was 100 % concordance in the identification of Mycobacterium species in 295 clinical isolates between the PCR-REBA Myco-ID and the QMAP system. Our study showed that 10 (66.7 %) of 15 M. abscessus complex identified by the QMAP system were identified as M. massiliense using PCR-REBA Myco-ID. PCR-REBA Myco-ID was able to discriminate between M. abscessus and M. massiliense, while the QMAP system only detected M. abscessus complex. PCR-REBA is a highly sensitive and specific probe-based method where multiple oligonucleotide probes are immobilized on nitrocellulose strips, and hybridized with biotin-labelled PCR products, and results are rapidly derived within 4 h [28] . However, when multiple tests are performed, it might take longer to get the results because PCR-REBA is not an automated system.
The QMAP system is a molecular diagnostic tool with the capacity to analyse nucleic acids and proteins. This assay is comparatively easy to perform (operation of equipment and software program) and rapid (less than 3 h for 96 tests). The magnetic microdiscs used in this study are the original technology of QuantaMatrix and have high chemical resistance and physical stability, reduced nonspecific adsorption and increased tolerance to physically taxing processes like sonication [18] . The coupled microdiscs with probes complementary to the target sequences show strong fluorescence relative to other probe-attached particles. The QMAP system improves accuracy because it allows 12 fields (x-axis 03Ây-axis 04) of one microwell to be captured, using the calculated mean value of fluorescence intensity. Thus, the QMAP system provides equal or superior accuracy compared to the conventional phenotypic methods, can readily differentiate bacterial species that have similar phenotypic characteristics and does not require subjective interpretation.
In terms of QMAP system specificity with 46 different Mycobacterium species, M. genavense was found positive by both the M. genavense/M. simiae and M. avium probes, and three Nocardia spp. (N. otitidiscaviarum, N. uniformis and M. abscessus (14) 1267-3545 2320 (±669) *Each of two isolates identified as M. intracellulare and M. abscessus complex by the KIT were determined as two co-infected with M. avium and M. intracellulare and two co-infected with M. avium and M. abscessus by the QMAP system and REBA Myco-ID, respectively. †Two cases confirmed as one M. gordonae and one M. mucogenicum by rpoB sequence analysis were identified as one M. gordonae and M. mucogenicum mixed and one M. avium and M. mucogenicum mixed by the REBA Myco-ID and QMAP systems, respectively.
ND,
Mycobacterium species was not determined.
N. vaccinii) were positive with the Mycobacterium genusspecific probe. The homology of rpoB genes between the M. genavense/M. simiae probe and the M. avium probe, and the Mycobacterium genus-specific probe and Nocardia spp. had high levels of identity (i.e. >95 %) based on the identity of sequences aligned with an NCBI BLAST [29] . The QMAP system M. kansasii probe was positive for M. kansasii and M. gastri. The M. kansasii and M. gastri species share an identical 16S rDNA sequence and differentiation between these species is possible by differences in the internal transcribed spacer and hsp65 sequences. M. kansasii is known to be the aetiological agent of pulmonary diseases resembling TB, whereas M. gastri is not frequently encountered in the clinical laboratory [30] .
In a pilot study, we tested the QMAP system with 55 AFB smear-positive (>1+) frozen residual sputum samples. Of these, 51 (92.7 %) were positive, 34 MTBC and 17 NTM [M. intracellulare (n=7), M. abscessus (n=7) and M. avium (n=3)]. Four cases (two M. intracellulare, one M. avium and one M. abscessus) of 1+ AFB smear samples were negative, indicating the need for sensitivity improvement. In addition, the QMAP system was negative for 30 normal (non-TB) samples that were AFB smear-and culture-negative (data not shown). The concordance of the QMAP system for direct specimens was 95.3 % (81/85, 95 % CI 0.8815-0.9852, P<0.0001). However, further study is necessary to identify the species in direct respiratory specimens, given the importance of accurate and rapid identification of MTBC and NTM species. The capacity of the coded QMAP microdiscs is more than 40 probes, leaving the possibility for increasing effectiveness of the QMAP system through the addition of drug-resistance-specific probes to detect rifampicin-or isoniazid-resistant TB.
The QMAP system is a fully automated magnetic beadbased assay system, including the washing and hybridization steps, and scanning for interpretation. Testing 96 samples took no longer than 3 h, including 30 min for DNA preparation and 1.5 h for target DNA amplification. The QMAP system is a useful tool for the rapid differentiation of MTBC and NTM strains and for clear identification of Mycobacterium species as the causative agent of disease, facilitating rapid selection of the appropriate therapeutic response. 
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